49 results on '"Falk, C"'
Search Results
2. Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer
3. Role of tumour-free margin distance for loco-regional control in vulvar cancer—a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study
4. Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
5. (1276) - Combined Heart and Lung Transplantation Across Preformed Donor-Specific Antibodies Using a Peritransplant Desensitization Protocol
6. (1009) - Patterns of Ventilation and Perfusion in the Early Post-Transplant Lung Allograft Using the Automatic Lung Parameter Estimator (ALPE)
7. (699) - Ten-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies After Lung Transplantation
8. (657) - Longitudinal Dynamics of the NK Cell Repertoire After Lung Transplantation and Their Potential Role for Control in CMV Reactivation
9. (605) - Outcomes in Lung Transplantation: Going Beyond a One-Size Fits All Approach?
10. Comparison of re-operation rates and complication rates after total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH)
11. (348) Longitudinal Dynamics of SARS-CoV-2 Spike-Specific Antibody Responses in Patients on Waiting List and after Lung Transplantation
12. (988) Coincidence of Early Graft Rejection and Replication of Human Herpesvirus 6 in the Donor Heart Associated with a CD38+ Lineage of Negative T Cells
13. (882) Nine-Year Results of an IgA-And IgM-Enriched Human Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies after Lung Transplantation
14. (410) Perioperative Desensitization Changes the Plasma Cytokine Milieu in Lung Transplant Patients with Preformed Donor Specific Antibodies
15. Risk Factors for the Development of Early Anti-HLA Donor Specific Antibodies After Lung Transplantation: The Role of Primary Graft Dysfunction
16. Perioperative Desensitization with IgA- and IgM-Enriched Human Immunoglobulins Allows Safe Lung Transplantation in Patients with Preformed Donor Specific Antibodies
17. Eight-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies After Lung Transplantation
18. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
19. Regulatory T Cells and the Effect of Ex Vivo Preservation on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model
20. Ex Situ Heart Perfusion and Standard of Care Cold Storage Differentially Affect the Ischemic Secretome of Donor Hearts in Perfusates but Not the Reperfusion Response in Recipient Plasma
21. Six-Year Results of an IgA- and IgM-Enriched Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies in Lung Transplantation
22. Correlation of CLAD in Lung Transplant Recipients with Transplant Arteriosclerosis in Humanized Mice: A 5-years Follow Up Analysis
23. Inflammatory Response after Immediate versus Delayed Ex-Vivo Lung Perfusion in a Porcine Cardiac Arrest Donation Model
24. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
25. Heart-Associated Cytokine and Endothelial Patterns Dominate the Ischemia Reperfusion Response in Recipients of Combined Heart/Lung Transplantation in Comparison to Lung Transplantation
26. Effects of Ex Vivo Perfusion and Il-6 Receptor Blockade on Ischemia Reperfusion Injury in Cardiac Transplantation
27. The Frequency of Tissue-Resident Donor T and NK Cells in Peripheral Blood after Lung Transplantation is Modulated by Normothermic Ex Vivo Lung
28. Linking CLAD in Lung Transplant Recipients after 3 Years Follow Up with Transplant Arteriosclerosis in Humanized Mice
29. Donor T and NK Cells are Derived from the Donor Lung Parenchyme and Represent Tissue-Resident Memory Cells - An Important Feature for Tolerance Development
30. (539) - Cytokine Dynamics Insights into Improved Lung Preservation Using the Organ Care System in a Porcine Transplantation Model in Comparison to the INSPIRE Trial
31. (538) - Ischemia Reperfusion Injury Significantly Differs Between Lung vs. Heart Transplantation with Respect to Lead Cytokines and Correlation to Clinical Outcome
32. (510) - After Clinical Lung Transplantation, NK Cells with a Lung-Resident Phenotype Represent the Most Prominent Donor Passenger Leukocyte Subset
33. (202) - Improved Lung Preservation in the Organ Care System in a Porcine Transplantation Setting Modelled After the INSPIRE Trial Triggers a Proregulatory T Cell Phenotype
34. (185) - Linking Early Humoral Sensitization in Lung Transplant Recipients with Even Earlier Cellular Alloreactivity in Humanized Mice
35. (187) - Leukocytes from Lung Transplant Recipients with Severe Primary Graft Dysfunction Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo
36. (957) - Early Natural Killer Frequencies and Chronic Lung Allograft Dysfunction Two Years After Lung Transplantation
37. (726) - Immune Monitoring-Guided Treatment of a Pediatric Patient with Sequential GvHD, Acute Rejection and CMV Infection Following Lung Transplantation
38. (492) - Linking Chronic Lung Allograft Dysfunction with Early Immunologic Events in a Humanized Mouse Model
39. 3-Years results after Chevron osteotomies using a titanium and a magnesium compression screw
40. (347) - Early Donor Specific Antibodies After Lung Transplantation Lead to an Increase of CD56+CD16+ NK Cells in Peripheral Blood
41. P0667 : Interruption of nucleos(t)ide analogue therapy for HBeAg-negative chronic hepatitis B – A new concept to achieve HBsAg decline?
42. (25) - Modulation of Immune-Mediators From Donor Lungs Using the Organ Care System® - A Potential Mechanism for Improved Outcome
43. 987 Molecular Mechanisms of Sorafenib-induced Apoptosis in Cancer Cells
44. P01-511 - Scientometric study of scientific production in psyciatry
45. CD6-depleted mobilized stem cells for modification of HVG and GVH reactions after HLA-haploidentical marrow transplantation
46. Pre-investigation of the subsoil developments in construction of the 4th Elbe Tunnel Tube
47. Experimental and analytical modelling of pipebursting ground displacements
48. HLA-antigens, crossmatch- and MLC-reactivity in women with previous habitual abortions
49. Lymphocyte subpopulations during pregnancy in women with habitual abortion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.